Abstract
| Original language | English |
|---|---|
| Type | Blog entry |
| Media of output | BMJ Opinion blog |
| Publication status | Published - 19 Jul 2019 |
Publication series
| Name | BMJ Blogs |
|---|
Fingerprint
Cite this
}
Implications of “no deal” Brexit for orphan and paediatric medicines. / Elborn, Joseph; Flear, Mark; Downey, Damian.
2019, Blog entry. (BMJ Blogs).Research output: Other contribution
TY - GEN
T1 - Implications of “no deal” Brexit for orphan and paediatric medicines
AU - Elborn, Joseph
AU - Flear, Mark
AU - Downey, Damian
PY - 2019/7/19
Y1 - 2019/7/19
N2 - In the event of a “no deal” Brexit some of the UK’s most vulnerable, especially children with rare diseases, may lose access to the best medicine available, say Stuart Elborn, Mark Flear, and Damian Downey.
AB - In the event of a “no deal” Brexit some of the UK’s most vulnerable, especially children with rare diseases, may lose access to the best medicine available, say Stuart Elborn, Mark Flear, and Damian Downey.
M3 - Other contribution
T3 - BMJ Blogs
ER -